BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21933882)

  • 1. TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer.
    Lu H; Yang X; Duggal P; Allen CT; Yan B; Cohen J; Nottingham L; Romano RA; Sinha S; King KE; Weinberg WC; Chen Z; Van Waes C
    Cancer Res; 2011 Nov; 71(21):6867-77. PubMed ID: 21933882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TNF-α modulates genome-wide redistribution of ΔNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer.
    Si H; Lu H; Yang X; Mattox A; Jang M; Bian Y; Sano E; Viadiu H; Yan B; Yau C; Ng S; Lee SK; Romano RA; Davis S; Walker RL; Xiao W; Sun H; Wei L; Sinha S; Benz CC; Stuart JM; Meltzer PS; Van Waes C; Chen Z
    Oncogene; 2016 Nov; 35(44):5781-5794. PubMed ID: 27132513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer.
    Lu H; Yan C; Quan XX; Yang X; Zhang J; Bian Y; Chen Z; Van Waes C
    Neoplasia; 2014 Oct; 16(10):789-800. PubMed ID: 25379016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 homologue DeltaNp63alpha interacts with the nuclear factor-kappaB pathway to modulate epithelial cell growth.
    King KE; Ponnamperuma RM; Allen C; Lu H; Duggal P; Chen Z; Van Waes C; Weinberg WC
    Cancer Res; 2008 Jul; 68(13):5122-31. PubMed ID: 18593911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis.
    Rocco JW; Leong CO; Kuperwasser N; DeYoung MP; Ellisen LW
    Cancer Cell; 2006 Jan; 9(1):45-56. PubMed ID: 16413471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells.
    Gallant-Behm CL; Espinosa JM
    Cell Cycle; 2013 Feb; 12(3):409-16. PubMed ID: 23324337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p63 and p73: teammates or adversaries?
    Ratovitski E; Trink B; Sidransky D
    Cancer Cell; 2006 Jan; 9(1):1-2. PubMed ID: 16413463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells.
    Liu J; Uematsu H; Tsuchida N; Ikeda MA
    Mol Cancer; 2011 Jul; 10():95. PubMed ID: 21801448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.
    Dohn M; Zhang S; Chen X
    Oncogene; 2001 May; 20(25):3193-205. PubMed ID: 11423969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.
    Ruhul Amin AR; Thakur VS; Gupta K; Agarwal MK; Wald DN; Shin DM; Agarwal ML
    Oncogene; 2013 Feb; 32(7):920-9. PubMed ID: 22430213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosomal proteins L11 and L5 activate TAp73 by overcoming MDM2 inhibition.
    Zhou X; Hao Q; Zhang Q; Liao JM; Ke JW; Liao P; Cao B; Lu H
    Cell Death Differ; 2015 May; 22(5):755-66. PubMed ID: 25301064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
    Rahman MA; Amin AR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG; Shin DM
    Clin Cancer Res; 2013 Jul; 19(13):3416-28. PubMed ID: 23719266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RACK1 and stratifin target DeltaNp63alpha for a proteasome degradation in head and neck squamous cell carcinoma cells upon DNA damage.
    Fomenkov A; Zangen R; Huang YP; Osada M; Guo Z; Fomenkov T; Trink B; Sidransky D; Ratovitski EA
    Cell Cycle; 2004 Oct; 3(10):1285-95. PubMed ID: 15467455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.
    Yang X; Lu H; Yan B; Romano RA; Bian Y; Friedman J; Duggal P; Allen C; Chuang R; Ehsanian R; Si H; Sinha S; Van Waes C; Chen Z
    Cancer Res; 2011 May; 71(10):3688-700. PubMed ID: 21576089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.
    Tophkhane C; Yang SH; Jiang Y; Ma Z; Subramaniam D; Anant S; Yogosawa S; Sakai T; Liu WG; Edgerton S; Thor A; Yang X
    PLoS One; 2012; 7(8):e43564. PubMed ID: 22952705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E1A activates transcription of p73 and Noxa to induce apoptosis.
    Flinterman M; Guelen L; Ezzati-Nik S; Killick R; Melino G; Tominaga K; Mymryk JS; Gäken J; Tavassoli M
    J Biol Chem; 2005 Feb; 280(7):5945-59. PubMed ID: 15572378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SATB2 augments ΔNp63α in head and neck squamous cell carcinoma.
    Chung J; Lau J; Cheng LS; Grant RI; Robinson F; Ketela T; Reis PP; Roche O; Kamel-Reid S; Moffat J; Ohh M; Perez-Ordonez B; Kaplan DR; Irwin MS
    EMBO Rep; 2010 Oct; 11(10):777-83. PubMed ID: 20829881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of TAp73 by platinum-based compounds to overcome drug resistance in p53 dysfunctional chronic lymphocytic leukemia.
    Tonino SH; Mulkens CE; van Laar J; Derks IA; Suo G; Croon-de Boer F; van Oers MH; Eldering E; Wang JY; Kater AP
    Leuk Lymphoma; 2015; 56(8):2439-47. PubMed ID: 25511680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melphalan-induced apoptosis of EBV-transformed B cells through upregulation of TAp73 and XAF1 and nuclear import of XPA.
    Park GB; Kim YS; Kim D; Kim S; Lee HK; Cho DH; Lee WJ; Hur DY
    J Immunol; 2013 Dec; 191(12):6281-91. PubMed ID: 24249729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
    Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
    Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.